In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Example: SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Example solution: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Example explanation: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.

Problem: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Tobacco Regulatory Fairness Act of
2000''.

SEC. 2. FINDINGS.

Congress makes the following findings:
(1) Cigarette smoking and tobacco use cause approximately
450,000 deaths each year in the United States.
(2) Cigarette smoking accounts for approximately
$65,000,000,000 in lost productivity and health care costs.
(3) In spite of the well-established dangers of cigarette
smoking and tobacco use, there is no Federal agency that has
any authority to regulate the manufacture, sale, distribution,
and use of tobacco products.
(4) The tobacco industry spends approximately
$4,000,000,000 each year to promote tobacco products.
(5) Each day 3,000 children try cigarettes for the first
time, many of whom become lifelong addicted smokers.
(6) There is no minimum age requirement in Federal law that
an individual must reach to legally buy cigarettes and other
tobacco products.
(7) The Food and Drug Administration is the most qualified
Federal agency to regulate tobacco products.
(8) It is inconsistent for the Food and Drug Administration
to regulate the manufacture, sale, and distribution of other
nicotine-containing products used as substitutes for cigarette
smoking and tobacco use and not be able to regulate tobacco
products in a comparable manner.

SEC. 3. DEFINITIONS.

Section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
321) is amended by adding at the end the following:
''(kk) The term 'tobacco product' means cigarettes, cigars, little
cigars, pipe tobacco, smokeless tobacco, snuff, and chewing tobacco.
''(ll) The term 'tobacco additive' means any substance the intended
use of which results or may reasonably be expected to result, directly
or indirectly, in its becoming a component or otherwise affecting the
characteristics of any tobacco product.
''(mm) The term 'constituent' means any element of cigarette
mainstream or sidestream smoke which is present in quantities which
represent a potential health hazard or where the health effect is
unknown.
''(nn) The term 'tar' means mainstream total articulate matter
minus nicotine and water.''.

SEC. 4. ENFORCEMENT.

Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
331) is amended--
(1) in subsections (a), (b), (c), (g), and (k), by striking
''or cosmetic'' and inserting ''cosmetic, or tobacco product'';
and
(2) by adding at the end the following:
''(u) The manufacture, sale, distribution, and advertising of
tobacco products in violation of regulations promulgated by the
Secretary pursuant to chapter X.''.

SEC. 5. REGULATION OF TOBACCO PRODUCTS.

The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) is
amended by adding at the end the following:

''CHAPTER X--TOBACCO PRODUCTS

''SEC. 1000. REGULATION OF TOBACCO PRODUCTS.

''(a) Regulations.--Not later than 1 year after the date on which
the Secretary receives the recommendations described in section
1003(f), the Secretary shall promulgate regulations governing the
manufacture, sale, and distribution of tobacco products in accordance
with the provisions of the chapter.
''(b) Food and Drug Administration.--Regulations promulgated under
subsection (a) shall designate the Food and Drug Administration as the
Federal agency that regulates the manufacture, distribution, and sale
of tobacco products.
''(c) Limitation.--Regulations promulgated under subsection (a) may
not prohibit the manufacture, distribution, or sale of a tobacco
product solely on the basis that such product causes a disease.
''(d) Sale or Distribution.--Under regulations promulgated under
subsection (a) it shall be unlawful to--
''(1) sell a tobacco product to an individual under the age
of 18 years;
''(2) sell a tobacco product to an individual if such
tobacco product is intended for use by an individual under the
age of 18 years; and
''(3) sell or distribute a tobacco product if the label of
such product does not display the following statement: 'Federal
Law Prohibits Sale To Minors'.
''(e) Manufacturing.--Regulations promulgated under subsection (a)
governing the manufacture of tobacco products shall--
''(1) require that all additives used in the manufacture of
tobacco products are safe; and
''(2) classify as a drug any nicotine-containing product
that does not meet the definition of a tobacco product.

''SEC. 1001. ADULTERATED TOBACCO PRODUCTS.

''(a) In General.--A tobacco product shall be deemed to be
adulterated--
''(1) if such product consists in whole or in part of any
filthy, putrid, or decomposed substance, or is otherwise
contaminated by any poisonous or deleterious substance that may
render such product injurious to health;
''(2) if such product has been prepared, packed, or held
under insanitary conditions in which such product may have been
contaminated with filth, or in which such product may have been
rendered injurious to health; and
''(3) if the container for such product is composed, in
whole or in part, of any poisonous or deleterious substance
that may render the contents of such product injurious to
health.
''(b) Regulations.--The Secretary may by regulation prescribe good
manufacturing practices for tobacco products. Such regulations may be
modeled after current good manufacturing practice regulations for other
products regulated under this Act.

''SEC. 1002. MISBRANDED TOBACCO PRODUCTS.

''A tobacco product shall be deemed to be misbranded--
''(1) if the labeling of such product is false or
misleading in any particular;
''(2) if in package form unless such product bears a label
containing--
''(A) the name and place of business of the tobacco
product manufacturer, packer, or distributor; and
''(B) an accurate statement of the quantity of the
contents in terms of weight, measure, or numerical
count,
except that under subparagraph (B) of this paragraph reasonable
variations shall be permitted, and exemptions as to small
packages shall be established, by regulations promulgated by
the Secretary;
''(3) if any word, statement, or other information required
by or under authority of this chapter to appear on the label or
labeling is not prominently placed thereon with such
conspicuousness (as compared with other words, statements or
designs in the labeling) and in such terms as to render it
likely to be read and understood by the ordinary individual
under customary conditions of purchase and use;
''(4) if such product has an established name, unless its
label bears, to the exclusion of any other nonproprietary name,
its established name is prominently printed in type as required
by the Secretary by regulation;
''(5) if the Secretary has issued regulations requiring
that the labeling of such product bear adequate directions for
use, or adequate warnings against use by children, that are
necessary for the protection of users unless the labeling of
such product conforms in all respects to such regulations; and
''(6) if such product was manufactured, prepared,
propagated, or processed in an establishment not duly
registered as required under section 1004.

''SEC. 1003. ADVISORY COMMITTEE.

''(a) Establishment.--There is established in the Food and Drug
Administration a Tobacco and Nicotine Products Advisory Committee
(hereafter referred to as the 'advisory committee').
''(b) Purpose.--The advisory committee shall assist the Secretary
in developing the regulations described in section 1000.
''(c) Membership.--
''(1) In general.--Not later than 60 days after the date of
enactment of this chapter, the Secretary shall appoint to the
advisory committee 10 individuals who are qualified by training
and experience to evaluate and make recommendations regarding
regulations governing the manufacture, distribution, sale,
labeling and advertising of tobacco products.
''(2) Experts.--The members described under paragraph (1),
not including the chairperson of such advisory committee, shall
consist of--
''(A) one expert in the field of nicotine
addiction;
''(B) one expert in the field of pharmacology;
''(C) one expert in the field of food and drug law;
''(D) one expert in the field of public education;
''(E) one expert in the field of toxicology;
''(F) two experts representing the interests of
family medicine, internal medicine, or pediatrics; and
''(G) two consumer representatives from the public
health community.
''(3) Ex officio.--The advisory committee shall have the
following as ex officio members:
''(A) The Director of the National Cancer
Institute.
''(B) The Director of the National Heart, Lung, and
Blood Institute.
''(C) The Director of National Institute on Drug
Abuse.
''(D) The Director of the Centers for Disease
Control and Prevention.
''(E) The Surgeon General of the Public Health
Service.
''(4) Chairperson.--The chairperson of the advisory
committee shall be appointed by the Secretary with the advice
and consent of the Commissioner of Food and Drugs.
''(d) Function.--The advisory committee shall--
''(1) review the available scientific evidence on the
effects of tobacco products on human health;
''(2) review the manufacturing process of tobacco products,
including the use of additives, sprayed on chemicals, product
development, and product manipulation;
''(3) review the role of nicotine as part of the smoking
habit, including its addictive properties and health effects;
and
''(4) review current Federal, State, and local laws
governing the manufacture, distribution, sale, labeling and
advertising of tobacco products.
''(e) Authority.--The advisory committee may hold hearings and
receive testimony and evidence as the committee determines to be
appropriate.
''(f) Recommendations.--Not later than 1 year after the Secretary
has appointed all members to the advisory committee, such committee
shall prepare and submit recommendations regarding regulations to be
promulgated under section 1000 to the Secretary.

''SEC. 1004. REGISTRATION.

''Not later than 120 days after the date of enactment of this
chapter, any manufacturer directly or indirectly engaged in the
manufacture, distribution, or sale of tobacco products shall register
with the Secretary the name and place of business of such manufacturer.

''SEC. 1005. ADVERTISING.

''(a) Regulations.--The Federal Trade Commission, after
consultation with the Secretary and upon receipt of approval by the
Secretary, shall promulgate regulations governing the advertising of
all tobacco products.
''(b) Labels.--The Federal Trade Commission, after consultation
with the Secretary and upon receipt of approval by the Secretary, may
promulgate regulations that--
''(1) modify the warning labels required by the Federal
Cigarette Labeling and Advertising Act (15 U.S.C. 1331 et seq.)
and the Comprehensive Smokeless Tobacco Health Education Act of
1986 (15 U.S.C. 4401 et seq.) if the modification in the
content of the label does not weaken the health message
contained in the label and is in the best interests of the
public health as determined by the Secretary; and
''(2) increase the size and placement of such required
labels.''.

SEC. 6. CONFORMING AMENDMENTS.

(a) Records.--Section 703 of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 373) is amended--
(1) by striking ''or cosmetics'' each place it appears and
inserting ''cosmetics, or tobacco products''; and
(2) by striking ''or cosmetic'' each place it appears and
inserting ''cosmetic, or tobacco product''.
(b) Factory Inspections.--Section 704 of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 374) is amended--
(1) in subsection (a)(1)--
(A) by striking ''or cosmetics'' each place it
appears and inserting ''cosmetics, or tobacco
products''; and
(B) by striking ''or restricted devices'' each
place it appears and inserting ''restricted devices, or
tobacco products''; and
(2) in subsection (b), by striking ''or cosmetic'' and
inserting ''cosmetic, or tobacco product''.
Solution: Requires the promulgation of regulations governing the manufacture, sale, and distribution of tobacco products. Define adulterated and misbranded tobacco products.
Establishes a Tobacco and Nicotine Products Advisory Committee.
Requires the promulgation of regulations governing the advertising of all tobacco products.